Q1 2025 · 13F-HR
CAXTON CORPholdings as filed
Filed 2025-05-15 · accession 0000919574-25-003127
$5.1M
Reported value
12
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 76200L309 | RZLT | REZOLUTE INC | $3.8M | 75.3% | 1,318,967 | Common | SOLE |
| 78463V107 | GLD | SPDR GOLD TR | $374,101 | 7.36% | 1,298 | Common | SOLE |
| 084670702 | BRK/B | BERKSHIRE HATHAWAY INC DEL | $248,816 | 4.90% | 467 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $199,327 | 3.92% | 34,073 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $142,562 | 2.81% | 10,941 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $82,584 | 1.63% | 43,465 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $61,943 | 1.22% | 17,851 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $44,354 | 0.87% | 22,981 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $41,721 | 0.82% | 13,287 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $35,901 | 0.71% | 16,393 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $13,203 | 0.26% | 17,488 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $11,263 | 0.22% | 18,403 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.